A common feature of human tumor tissue is mutant p53 protein accumulat
ion. Here we evaluate a new ''sandwich'' immunoassay for p53 protein i
ncorporating modifications to a previously reported method, including
the use of microtiter plates coated directly with the anti-p53 monoclo
nal antibody DO-1, a detergent- and mouse serum-containing sample dilu
ent, and a labeled secondary antibody diluent containing goat serum. T
he use of CM-1 antiserum to probe the immunocaptured p53 and the detec
tion of bound complexes by a labeled secondary antibody allows couplin
g to a time-resolved fluorescence detection system. The new assay yiel
ded p53 concentrations comparable with those by the previous assay for
breast tumor cytosols (n = 198), nondiseased breast tissues (n = 70),
and five transformed cell lines, but showed differences in p53 values
measured in sera from patients without cancer (n = 78). These serum d
ifferences were found to reflect nonspecific interferences affecting t
he original method, which implies that the new immunoassay has improve
d specificity for serum p53 quantification.